nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adrenal incidentalomas: Experience from a retrospective study in a Chinese population
|
Bin, Xu |
|
2011 |
29 |
3 |
p. 270-274 5 p. |
artikel |
2 |
Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features
|
Wang, Wei |
|
2011 |
29 |
3 |
p. 244-251 8 p. |
artikel |
3 |
Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis
|
Leite, Katia R.M. |
|
2011 |
29 |
3 |
p. 265-269 5 p. |
artikel |
4 |
Clinical application of a 3D ultrasound-guided prostate biopsy system
|
Natarajan, Shyam |
|
2011 |
29 |
3 |
p. 334-342 9 p. |
artikel |
5 |
Commentary of “Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program”
|
Smith, Joseph A. |
|
2011 |
29 |
3 |
p. 351- 1 p. |
artikel |
6 |
Commentary on “A comparison of outcomes for interfascial and intrafascial nerve-sparing radical prostatectomy”
|
Smith, Joseph A. |
|
2011 |
29 |
3 |
p. 348- 1 p. |
artikel |
7 |
Commentary on “Effects of prostate-specific antigen testing on familial prostate cancer risk estimates”
|
Smith, Joseph A. |
|
2011 |
29 |
3 |
p. 348-349 2 p. |
artikel |
8 |
Commentary on “Impact of prior prostate radiation on complications after radical prostatectomy”
|
Smith, Joseph A. |
|
2011 |
29 |
3 |
p. 349- 1 p. |
artikel |
9 |
Commentary on “Mortality results from the Göteborg randomized population-based prostate-cancer screening trial”
|
Smith, Joseph A. |
|
2011 |
29 |
3 |
p. 350- 1 p. |
artikel |
10 |
Commentary on “Prognostic significance of undetectable ultrasensitive prostate-specific antigen nadir after radical prostatectomy”
|
Smith, Joseph A. |
|
2011 |
29 |
3 |
p. 350-351 2 p. |
artikel |
11 |
Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival
|
Chung, Benjamin I. |
|
2011 |
29 |
3 |
p. 314-318 5 p. |
artikel |
12 |
Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer
|
Yafi, Faysal A. |
|
2011 |
29 |
3 |
p. 309-313 5 p. |
artikel |
13 |
Contents
|
|
|
2011 |
29 |
3 |
p. iv- 1 p. |
artikel |
14 |
Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer
|
Seitz, Michael |
|
2011 |
29 |
3 |
p. 295-301 7 p. |
artikel |
15 |
Editorial Board
|
|
|
2011 |
29 |
3 |
p. ii- 1 p. |
artikel |
16 |
Imaging guidance in minimally invasive prostatectomy
|
Gupta, Angela D. |
|
2011 |
29 |
3 |
p. 343-346 4 p. |
artikel |
17 |
Information for Authors
|
|
|
2011 |
29 |
3 |
p. IBC- 1 p. |
artikel |
18 |
Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder
|
Halachmi, Sarel |
|
2011 |
29 |
3 |
p. 259-264 6 p. |
artikel |
19 |
Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features
|
De Giorgi, Ugo |
|
2011 |
29 |
3 |
p. 284-290 7 p. |
artikel |
20 |
Masthead
|
|
|
2011 |
29 |
3 |
p. IFC- 1 p. |
artikel |
21 |
New technology in urology: Balancing risk and reward
|
Makarov, Danil V. |
|
2011 |
29 |
3 |
p. 324- 1 p. |
artikel |
22 |
No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes
|
Jaboin, Jerry J. |
|
2011 |
29 |
3 |
p. 319-323 5 p. |
artikel |
23 |
Patients and solipsism: The psychology of decision making for prostate cancer treatment
|
Chamie, Karim |
|
2011 |
29 |
3 |
p. 233-234 2 p. |
artikel |
24 |
Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer
|
Porter, Michael P. |
|
2011 |
29 |
3 |
p. 252-258 7 p. |
artikel |
25 |
Potential use of circulating endothelial cells as a biomarker of renal cell carcinoma
|
Tan, Kevin V.S. |
|
2011 |
29 |
3 |
p. 237-243 7 p. |
artikel |
26 |
Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: Feasibility in Asian population
|
Lai, Miranda H.Y. |
|
2011 |
29 |
3 |
p. 275-279 5 p. |
artikel |
27 |
Predictors of costs for robotic-assisted laparoscopic radical prostatectomy
|
Bolenz, Christian |
|
2011 |
29 |
3 |
p. 325-329 5 p. |
artikel |
28 |
Should decision models drive the decision for prostate biopsy?
|
Jones, Stephen |
|
2011 |
29 |
3 |
p. 235-236 2 p. |
artikel |
29 |
Survey Section Editorial Board
|
|
|
2011 |
29 |
3 |
p. 347- 1 p. |
artikel |
30 |
The application of natural orifice surgery for adenocarcinoma of the prostate
|
Duty, Brian |
|
2011 |
29 |
3 |
p. 330-333 4 p. |
artikel |
31 |
The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy
|
Nguyen, Paul L. |
|
2011 |
29 |
3 |
p. 302-308 7 p. |
artikel |
32 |
The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer
|
Murgel de Castro Santos, Luis Eduardo |
|
2011 |
29 |
3 |
p. 291-294 4 p. |
artikel |
33 |
What is the adequacy of biopsies for prostate sampling?
|
Dogan, Hasan Serkan |
|
2011 |
29 |
3 |
p. 280-283 4 p. |
artikel |